Pentose phosphate pathway and NADPH metabolism

Handbook of Neurochemistry and Molecular Neurobiology: Brain Energetics. Integration of Molecular and Cellular Processes

Volumn , Issue , 2007, Pages 41-62

  Dringen, R ^a,b   Hoepken, H H ^c   Minich, T ^c   Ruedig, C ^c  

^a UNIVERSITY OF BREMEN   (Germany)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900923605     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-30411-3_3     Document Type: Chapter

References (198)

1. Adams JD Jr, Klaidman LK, Chang ML, Yang J. 2001. Brain oxidative stress-analytical chemistry and thermodynamics of glutathione and NADPH. Curr Top Med Chem 1:473-482.
2. Appel SH, Parrot BL. 1970. Hexose monophosphate pathway in synapses. J Neurochem 17:1619-1626.
3. Arkblad EL, Egorov M, Shakhparonov M, Romanova L, Polzikov M, et al. 2002. Expression of proton-pumping nicotinamide nucleotide transhydrogenase in mouse, human brain and C.elegans. Comp Biochem Physiol B Biochem Mol Biol 133:13-21.
4. Askar MA, Sumathy K, Baquer NZ. 1996. Regulation and properties of purified glucose-6-phosphate dehydrogenase from rat brain. Indian J Biochem Biophys 33:512-518.
5. Au SW, Gover S, Lam VM, Adams MJ. 2000. Human glucose-6-phosphate dehydrogenase: The crystal structure reveals a structural NADP (+) molecule and provides insights into enzyme deficiency. Structure Fold Des 8:293-303.
6. Au SW, Naylor CE, Gover S, Vandeputte-Rutten L, Scopes DA, et al. 1999. Solution of the structure of tetrameric human glucose 6-phosphate dehydrogenase by molecular replacement. Acta Crystallogr D Biol Crystallogr (Pt 4): 55 826-834.
7. Bagdasarian G, Hulanicka D. 1965. Changes of mitochondrial glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase during brain development. Biochim Biophys Acta 99:367-369.
8. Baizabal JM, Furlan-Magaril M, Santa-Olalla J, Covarrubias L. 2003. Neural stem cells in development and regenerative medicine. Arch Med Res 34:572-588.
9. Banki K, Colombo E, Sia F, Halladay D, Mattson DH, et al. 1994a. Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J Exp Med 180:1649-1663.
10. Banki K, Eddy RL, Shows TB, Halladay DL, Bullrich F, et al. 1997. The human transaldolase gene (TALDO1) is located on chromosome 11 at p15.4-p15.5. Genomics 45:233-238.
11. Banki K, Halladay D, Perl A. 1994b. Cloning and expression of the human gene for transaldolase. A novel highly repetitive element constitutes an integral part of the coding sequence. J Biol Chem 269:2847-2851.
12. Baquer NZ, Hothersall JS, Greenbaum AL, McLean P. 1975. The modifying effect of manganese on the enzymic profiles and pathways of carbohydrate metabolism in rat liver and adipose tissue during development. Biochem Biophys Res Commun 62:634-641.
13. Baquer NZ, Hothersall JS, McLean P. 1988. Function and regulation of the pentose phosphate pathway in brain. Curr Top Cell Regul 29:265-289.
14. Baquer NZ, Hothersall JS, McLean P, Greenbaum AL. 1977. Aspects of carbohydrate metabolism in developing brain. Dev Med Child Neurol 19:81-104.
15. Baquer NZ, McLean P, Greenbaum AL. 1973. Enzymic differentiation in pathways of carbohydrate metabolism in developing brain. Biochem Biophys Res Commun 53:1282-1288.
16. Barañano DE, Ferris CD, Snyder SH. 2001. Atypical neural messengers. Trends Neurosci 24:99-106.
17. Barañano DE, Rao M, Ferris CD, Snyder SH. 2002. Biliverdin reductase: A major physiologic cytoprotectant. Proc Natl Acad Sci USA 99:16093-16098.
18. Barañano DE, Snyder SH. 2001. Neural roles for heme oxygenase: Contrasts to nitric oxide synthase. Proc Natl Acad Sci USA 98:10996-11002.
19. Bauer HP, Srihari T, Jochims JC, Hofer HW. 1983. 6- phosphogluconolactonase. Purification, properties and activities in various tissues. Eur J Biochem 133:163-168.
20. Ben Yoseph O, Boxer PA, Ross BD. 1994a. Oxidative stress in the central nervous system: Monitoring the metabolic response using the pentose phosphate pathway. Dev Neurosci 16:328-336.
21. Ben Yoseph O, Boxer PA, Ross BD. 1996a. Assessment of the role of the glutathione and pentose phosphate pathways in the protection of primary cerebrocortical cultures from oxidative stress. J Neurochem 66:2329-2337.
22. Ben Yoseph O, Boxer PA, Ross BD. 1996b. Noninvasive assessment of the relative roles of cerebral antioxidant enzymes by quantitation of pentose phosphate pathway activity. Neurochem Res 21:1005-1012.
23. 13C2, 6, 6-2H2]glucose and microdialysis. J Neurochem 64:1336-1342.
24. Ben Yoseph O, Kingsley PB, Ross BD. 1994b. Metabolic loss of deuterium from isotopically labeled glucose. Magn Reson Med 32:405-409.
25. Bhadbhade MM, Adams MJ, Flynn TG, Levy HR. 1987. Sequence identity between a lysine-containing peptide from Leuconostoc mesenteroides glucose-6-phosphate dehydrogenase and an active site peptide from human erythrocyte glucose-6-phosphate dehydrogenase. FEBS Lett 211:243-246.
26. Biagiotti E, Guidi L, Del Grande P, Ninfali P. 2003. Glucose-6-phosphate dehydrogenase expression associated with NADPH-dependent reactions in cerebellar neurons. Cerebellum 2:178-183.
27. Biagiotti E, Ferri, P, Dringen, R, del Grande, P, Ninfali, P. 2005. NADPH-dependent reactions correlate with glucose-6-phosphate dehydrogenase in the rat olfactory bulb: An immunohistochemical and histochemical study. J Neurosci Res 80:434-441.
28. Bigl M, Bruckner MK, Arendt T, Bigl V, Eschrich K. 1999. Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease. J Neural Transm 106:499-511.
29. Bilger A, Nehlig A. 1992. Quantitative histochemical changes in enzymes involved in energy metabolism in the rat brain during postnatal development. II. Glucose-6-phosphate dehydrogenase and beta-hydroxybutyrate dehydrogenase. Int J Dev Neurosci 10:143-152.
30. Björkhem I, Meaney S. 2004. Brain cholesterol: Long secret life behind a barrier. Arterioscler Thromb Vasc Biol 24:806-815.
31. Blass JP, Piacentini S, Boldizsar E, Baker A. 1982. Kinetic studies of mouse brain transketolase. J Neurochem 39:729-733.
32. Bokoch GM, Knaus UG. 2003. NADPH oxidases: Not just for leukocytes anymore! Trends Biochem Sci 28:502-508.
33. Bolaños JP, Cidad P, García-Nogales P, Delgado-Esteban M, Fernández E, et al. 2004. Regulation of glucose metabolism by nitrosative stress in neural cells. Mol Aspects Med 25:61-73.
34. Brooks PJ. 2002. DNA repair in neural cells: Basic science and clinical implications. Mutat Res 509:93-108.
35. Bublitz C, Steavenson S. 1988. The pentose phosphate pathway in the endoplasmic reticulum. J Biol Chem 263:12849-12853.
36. Bukato G, Kochan Z, Swierczynski J. 1995. Purification and properties of cytosolic and mitochondrial malic enzyme isolated from human brain. Int J Biochem Cell Biol 27:47-54.
37. Cabezas H, Raposo RR, Melendez-Hevia E. 1999. Activity and metabolic roles of the pentose phosphate cycle in several rat tissues. Mol Cell Biochem 201:57-63.
38. Calingasan NY, Sheu KF, Baker H, Jung EH, Paoletti F, et al. 1995. Heterogeneous expression of transketolase in rat brain. J Neurochem 64:1034-1044.
39. Camardella L, Caruso C, Rutigliano B, Romano M, Di Prisco G, et al. 1988. Human erythrocyte glucose-6-phosphate dehydrogenase. Identification of a reactive lysyl residue labelled with pyridoxal 50-phosphate. Eur J Biochem 171:485-489.
40. Cammer W, Snyder DS, Zimmerman TR Jr, Farooq M, Norton WT. 1982. Glycerol phosphate dehydrogenase, glucose-6-phosphate dehydrogenase, and lactate dehydrogenase: Activities in oligodendrocytes, neurons, astrocytes, and myelin isolated from developing rat brains. J Neurochem 38:360-367.
41. Cammer W, Zimmerman TR Jr. 1982. Glycerolphosphate dehydrogenase, glucose-6-phosphate dehydrogenase, lactate dehydrogenase and carbonic anhydrase activities in oligodendrocytes and myelin: Comparisons between species and CNS regions. Brain Res 282:21-26.
42. Cho SW, Joshi JG. 1989. Inactivation of glucose-6-phosphate dehydrogenase isozymes from human and pig brain by aluminum. J Neurochem 53:616-621.
43. Clarke DD, Sokoloff L. 1999. Circulation and energy metabolism of the brain. Basic neurochemistry. Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD, editors. New York: Lippincott Williams & Wilkins; pp. 637-669.
44. Clarke JL, Mason PJ. 2003. Murine hexose-6-phosphate dehydrogenase: A bifunctional enzyme with broad substrate specificity and 6- phosphogluconolactonase activity. Arch Biochem Biophys. 415:229-234.
45. Clement MV, Long LH, Ramalingam J, Halliwell B. 2002. The cytotoxicity of dopamine may be an artefact of cell culture. J Neurochem 81:414-421.
46. Cohen P, Rosemeyer MA. 1969. Subunit interactions of glucose-6-phosphate dehydrogenase from human erythrocytes. Eur J Biochem 8:8-15.
47. Collard F, Collet JF, Gerin I, Veiga-da-Cunha M, Van Schaftingen E. 1999. Identification of the cDNA encoding human 6-phosphogluconolactonase, the enzyme catalyzing the second step of the pentose phosphate pathway (1). FEBS Lett 459:223-226.
48. Colombo E, Banki K, Tatum AH, Daucher J, Ferrante P, et al. 1997. Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. J Clin Invest 99:1238-1250.
49. Colton CA, Gilbert DL. 1987. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 223:284-288.
50. Conley A, Hinshelwood M. 2001. Mammalian aromatases. Reproduction 121:685-695.
51. Cunnane SC, Menard CR, Likhodii SS, Brenna JT, Crawford MA. 1999. Carbon recycling into de novo lipogenesis is a major pathway in neonatal metabolism of linoleate and alpha-linolenate. Prostaglandins Leukot Essent Fatty Acids 60:387-392.
52. de Almeida AF, Curi R, Newsholme P, Newsholme EA. 1989. Maximal activities of key enzymes of glutaminolysis, glycolysis, Krebs cycle and pentose-phosphate pathway of several tissues in mature and aged rats. Int J Biochem 21:937-940.
53. Domanska-Janik K. 1988. Hexose monophosphate pathway activity in normal and hypoxic rat brain. Resuscitation 16:79-90.
54. Dringen R. 2000. Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649-671.
55. Dringen R. 2005. Oxidative and anti-oxidative potential of brain microglial cells. Antioxid Redox Signal 7:1223-1233.
56. Dringen R, Gutterer JM. 2002. Glutathione reductase from bovine brain. Methods Enzymol 348:281-288.
57. Dringen R, Hamprecht B. 1997. Involvement of glutathione peroxidase and catalase in the disposal of exogenous 1.3 hydrogen peroxide by cultured astroglial cells. Brain Res 759:67-75.
58. Dringen R, Hirrlinger J. 2003. Glutathione pathways in the brain. Biol Chem 384:505-516.
59. Dringen R, Kussmaul L, Hamprecht B. 1998. Rapid clearance of tertiary butyl hydroperoxide by cultured astroglial cells via oxidation of glutathione. Glia 23:139-145.
60. Dringen R, Pawlowski PG, Hirrlinger J. 2005. Peroxide detoxification by brain cells. J Neurosci Res 79:157-165.
61. Edmond J, Robbins RA, Bergstrom JD, Cole RA, de Vellis J. 1987. Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture. J Neurosci Res 18:551-561.
62. Eftekharpour E, Holmgren A, Juurlink BH. 2000. Thioredoxin reductase and glutathione synthesis is upregulated by t-butylhydroquinone in cortical astrocytes but not in cortical neurons. Glia 31:241-248.
63. Egan RM, Sable HZ. 1981. Transketolase kinetics. The slow reconstitution of the holoenzyme is due to rate-limiting dimerization of the subunits. J Biol Chem 256:4877-4883.
64. El-Hassan A, Zubairu S, Hothersall JS, Greenbaum AL. 1981. Age-related changes in enzymes of rat brain. 1. Enzymes of glycolysis, the pentose phosphate pathway and lipogenesis. Enzyme 26:107-112.
65. Esplugues JV. 2002. NO as a signalling molecule in the nervous system. Br J Pharmacol 135:1079-1095.
66. Esposito M, Venkatesh V, Otvos L, Weng Z, Vajda S, et al. 1999. Human transaldolase and cross-reactive viral epitopes identified by autoantibodies of multiple sclerosis patients. J Immunol 163:4027-4032.
67. Felix K, Rockwood LD, Pretsch W, Nair J, Bartsch H, et al. 2002. Moderate G6PD deficiency increases mutation rates in the brain of mice. Free Radic Biol Med 32:663-673.
68. Filosa S, Fico A, Paglialunga F, Balestrieri M, Crooke A, et al. 2003. Failure to increase glucose consumption through the pentose-phosphate pathway results in the death of glucose-6-phosphate dehydrogenase gene-deleted mouse embryonic stem cells subjected to oxidative stress. Biochem J 370:935-943.
69. Friede RL, Bischhausen R. 1978. How do axons control myelin formation? The model of 6-aminonicotinamide neuropathy. J Neurol Sci 35:341-353.
70. Friede RL, Fleming LM, Knoller M. 1963. A comparative mapping of enzymes involved in hexosemonophosphate shunt and citric acid cycle in the brain. J Neurochem 10:263-277.
71. Gaitonde MK, Evison E, Evans GM. 1983. The rate of utilization of glucose via hexosemonophosphate shunt in brain. J Neurochem 41:1253-1260.
72. García-Nogales P, Almeida A, Bolaños JP. 2003. Peroxynitrite protects neurons against nitric oxide-mediated apoptosis. A key role for glucose-6-phosphate dehydrogenase activity in neuroprotection. J Biol Chem 278:864-874.
73. García-Nogales P, Almeida A, Fernández E, Medina JM, Bolaños JP. 1999. Induction of glucose-6-phosphate dehydrogenase by lipopolysaccharide contributes to preventing nitric oxide-mediated glutathione depletion in cultured rat astrocytes. J Neurochem 72:1750-1758.
74. Gibson GE, Ksiezak-Reding H, Sheu KF, Mykytyn V, Blass JP. 1984. Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal. Neurochem Res 9:803-814.
75. Gibson GE, Sheu KF, Blass JP, Baker A, Carlson KC, et al. 1988. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol 45:836-840.
76. Giguère JF, Butterworth RF. 1987. Activities of thiaminedependent enzymes in two experimental models of thiamine deficiency encephalopathy: 3. Transketolase. Neurochem Res 12:305-310.
77. Giuffrida AM. 1983. Nucleic acids in developing brain. Handbook of neurochemistry. Lajtha A, editor. New York: Plenum Press; pp. 227-250.
78. Gordon G, Mackow MC, Levy HR. 1995. On the mechanism of interaction of steroids with human glucose 6-phosphate dehydrogenase. Arch Biochem Biophys 318:25-29.
79. Green SP, Cairns B, Rae J, Errett-Baroncini C, Hongo JA, et al. 2001. Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system inflammation. J Cereb Blood Flow Metab 21:374-384.
80. Griffiths IR, Kelly PA, Grome JJ. 1981. Glucose utilization in the central nervous system in the acute gliopathy due to 6-aminonicotinamide. Lab Invest 44:547-552.
81. Gromer S, Urig S, Becker K. 2004. The thioredoxin system-from science to clinic. Med Res Rev 24:40-89.
82. Guerra RM, Melgar E, Villavicencio M. 1967. Alternative pathways of glucose metabolism in fetal rat brain. Biochim Biophys Acta 148:356-361.
83. Gutterer JM, Dringen R, Hirrlinger J, Hamprecht B. 1999. Purification of glutathione reductase from bovine brain, generation of an antiserum, and immunocytochemical localization of the enzyme in neural cells. J Neurochem 73:1422-1430.
84. Halliwell B. 2001. Role of free radicals in the neurodegenerative diseases: Therapeutic implications for antioxidant treatment. Drugs Aging 18:685-716.
85. Halliwell B, Gutteridge JMC. 1999. Free Radicals in Biology and Medicine. New York: Oxford University Press.
86. Hassel B. 2000. Carboxylation and anaplerosis in neurons and glia. Mol Neurobiol 22:21-40.
87. Heap LC, Pratt OE, Ward RJ, Waller S, Thomson AD, et al. 2002. Individual susceptibility to Wernicke-Korsakoff 1.3 syndrome and alcoholism-induced cognitive deficit: Impaired thiamine utilization found in alcoholics and alcohol abusers. Psychiatr Genet 12:217-224.
88. Hedlund E, Gustafsson JA, Warner M. 2001. Cytochrome P450 in the brain; a review. Curr Drug Metab 2:245-263.
89. Heinrich PC, Morris HP, Weber G. 1976. Behavior of transaldolase (EC 2. 2.1.2) and transketolase (EC 2.2.1.1) activities in normal, neoplastic, differentiating, and regenerating liver. Cancer Res 36:3189-3197.
90. Herken H, Lange K, Kolbe H. 1969. Brain disorders induced by pharmacological blockade of the pentose phosphate pathway. Biochem Biophys Res Commun 36:93-100.
91. Herken H, Meyer-Estorf G, Halbhubner K, Loos D. 1976. Spastic paresis after 6-aminonicotinamide: Metabolic disorders in the spinal cord and electromyographically recorded changes in the hind limbs of rats. Naunyn Schmiedebergs Arch Pharmacol 293:245-255.
92. Héroux M, Raghavendra RV, Lavoie J, Richardson JS, Butterworth RF. 1996. Alterations of thiamine phosphorylation and of thiamine-dependent enzymes in Alzheimer's disease. Metab Brain Dis 11:81-88.
93. Hirrlinger J, Schulz JB, Dringen R. 2002. Effects of dopamine on the glutathione metabolism of cultured astroglial cells: Implications for Parkinson's disease. J Neurochem 82:458-467.
94. Hothersall JS, Baquer N, Greenbaum AL, McLean P. 1979. Alternative pathways of glucose utilization in brain. Changes in the pattern of glucose utilization in brain during development and the effect of phenazine methosulfate on the integration of metabolic routes. Arch Biochem Biophys 198:478-492.
95. Hothersall JS, Greenbaum AL, McLean P. 1982. The functional significance of the pentose phosphate pathway in synaptosomes: Protection against peroxidative damage by catecholamines and oxidants. J Neurochem 39:1325-1332.
96. Huck JH, Verhoeven NM, Struys EA, Salomons GS, Jakobs C, et al. 2004. Ribose-5-phosphate isomerase deficiency: New inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy. Am J Hum Genet 74:745-751.
97. Innis SM. 2003. Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr 143:S1-S8.
98. Istvan ES, Deisenhofer J. 2000. The structure of the catalytic portion of human HMG-CoA reductase. Biochim Biophys Acta 1529:9-18.
99. Iwata H, Tonomura H, Matsuda T. 1988. Transketolase and 2-oxoglutarate dehydrogenase activities in the brain and liver of the developing rat. Experientia 44:780-781.
100. Jacquin-Becker C, Labourdette G. 1997. Regulation of aldose reductase expression in rat astrocytes in culture. Glia 20:135-144.
101. Jeffery J, Jörnvall H. 1983. Enzyme relationships in a sorbitol pathway that bypasses glycolysis and pentose phosphates in glucose metabolism. Proc Natl Acad Sci USA 80:901-905.
102. Jeyasingham MD, Pratt OE. 1988. Rat brain apotransketolase: Activation and inactivation. J Neurochem 50:1537-1541.
103. Jeyasingham MD, Pratt OE, Thomson AD, Shaw GK. 1986. Reduced stability of rat brain transketolase after conversion to the apo form. J Neurochem 47:278-281.
104. Jo SH, Son MK, Koh HJ, Lee SM, Song IH, et al. 2001. Control of mitochondrial redox balance and cellular defense against oxidative damage by mitochondrial NADP+-dependent isocitrate dehydrogenase. J Biol Chem 276:16168-16176.
105. Katsurada A, Iritani N, Fukuda H, Matsumura Y, Noguchi T, et al. 1989. Effects of nutrients and insulin on transcriptional and post-transcriptional regulation of glucose-6-phosphate dehydrogenase synthesis in rat liver. Biochim Biophys Acta 1006:104-110.
106. Kauffman FC. 1972. The quantitative histochemistry of enzymes of the pentose phosphate pathway in the central nervous system of the rat. J Neurochem 19:1-9.
107. Kirsch M, de Groot H. 2001. NAD (P) H, a directly operating antioxidant? FASEB J 15:1569-1574.
108. Kletzien RF, Harris PK, Foellmi LA. 1994. Glucose-6-phosphate dehydrogenase: A "housekeeping" enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. FASEB J 8:174-181.
109. Krieglstein J, Stock R. 1975. Decreased glycolytic flux rate in the isolated perfused rat brain after pretreatment with 6-aminonicotinamide. Naunyn Schmiedebergs Arch Pharmacol 290:323-327.
110. Kruger NJ, von Schaewen A. 2003. The oxidative pentose phosphate pathway: Structure and organisation. Curr Opin Plant Biol 6:236-246.
111. Krum JM. 1995. Age-dependent susceptibility of CNS glial populations in situ to the antimetabolite 6-aminonicotinamide. Mol Chem Neuropathol 26:79-94.
112. Kurz GM, Wiesinger H, Hamprecht B. 1993. Purification of cytosolic malic enzyme from bovine brain, generation of monoclonal antibodies, and immunocytochemical localization of the enzyme in glial cells of neural primary cultures. J Neurochem 60:1467-1474.
113. Kussmaul L, Hamprecht B, Dringen R. 1999. The detoxification of cumene hydroperoxide by the glutathione system of cultured astroglial cells hinges on hexose availability for the regeneration of NADPH. J Neurochem 73:1246-1253.
114. Kwee IL, Igarashi H, Nakada T. 1996. Aldose reductase and sorbitol dehydrogenase activities in diabetic brain: In vivo kinetic studies using 19F 3-FDG NMR in rats. Neuroreport 7:726-728.
115. Lakhman SS, Sharma P, Kaur G, Kaur G. 1994. Changes in glucose metabolism from discrete regions of rat brain and its relationship to reproductive failure during experimental diabetes. Mol Cell Biochem 141:97-102.
116. Landino LM, Iwig JS, Kennett KL, Moynihan KL. 2004. Repair of peroxynitrite damage to tubulin by the thioredoxin reductase system. Free Radic Biol Med 36:497-506.
117. Lange K, Kolbe H, Keller K, Herken H. 1970. der Kohlenhydratstoffwechsel des Gehirns nach Blockade des Pentose-Phosphat-Weges durch 6- Aminonicotinsäureamid. Hoppe-Seyler's Z Physiol Chem 351:1241-1252.
118. Lavigne MC, Malech HL, Holland SM, Leto TL. 2001. Genetic requirement of p47phox for superoxide production by murine microglia. FASEB J 15:285-287.
119. Lee AY, Chung SS. 1999. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J 13:23-30.
120. Lee SM, Koh HJ, Park DC, Song BJ, Huh TL, et al. 2002. Cytosolic NADP (+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells. Free Radic Biol Med 32:1185-1196.
121. Leong SF, Clark JB. 1984. Regional enzyme development in rat brain. Enzymes associated with glucose utilization. Biochem J 218:131-138.
122. +. Arch Biochem Biophys 326:145-151.
123. Loreck DJ, Galarraga J, Van der FJ, Phang JM, Smith BH, et al. 1987. Regulation of the pentose phosphate pathway in human astrocytes and gliomas. Metab Brain Dis 2:31-46.
124. Luzzatto L, Mehta A, Vulliamy T. 2001. Glucose 6-phosphate dehydrogenase deficiency. The metabolic & molecular base of inherited disease. Scriver CR, Beaudet AL, Sly WS, Valle D, editors. New York: McGraw-Hill; pp. 4517-4553.
125. Maeng O, Kim YC, Shin HJ, Lee JO, Huh TL, et al. 2004. Cytosolic NADP (+)-dependent isocitrate dehydrogenase protects macrophages from LPS-induced nitric oxide and reactive oxygen species. Biochem Biophys Res Commun 317:558-564.
126. Martins RN, Harper CG, Stokes GB, Masters CL. 1986a. Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. J Neurochem 46:1042-1045.
127. Martins RN, Stokes GB, Masters CL. 1986b. Regulation of liver and brain hexose monophosphate dehydrogenases by insulin and dietary intake in the female rat. Mol Cell Biochem 70:169-175.
128. Mason PJ, Stevens D, Diez A, Knight SW, Scopes DA, et al. 1999. Human hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) encoded at 1p36: Coding sequence and expression. Blood Cells Mol Dis 25:30-37.
129. Massod MF, McGuire SL, Werner KR. 1971. Analysis of blood transketolase activity. Am J Clin Pathol 55:465-470.
130. Mauch DH, Nägler K, Schumacher S, Göritz C, Müller EC, et al. 2001. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294:1354-1357.
131. Medina JM, Tabernero A. 2002. Astrocyte-synthesized oleic acid behaves as a neurotrophic factor for neurons. J Physiol Paris 96:265-271.
132. Meske V, Albert F, Richter D, Schwarze J, Ohm TG. 2003. Blockade of HMG-CoA reductase activity causes changes in microtubule-stabilizing protein tau via suppression of geranylgeranylpyrophosphate formation: Implications for Alzheimer's disease. Eur J Neurosci 17:93-102.
133. Miclet E, Stoven V, Michels PA, Opperdoes FR, Lallemand JY, et al. 2001. NMR spectroscopic analysis of the first two steps of the pentose-phosphate pathway elucidates the role of 6-phosphogluconolactonase. J Biol Chem 276:34840-34846.
134. +-dependent isocitrate dehydrogenases are expressed in cultured rat neurons, astrocytes, oligodendrocytes and microglial cells. J Neurochem 86:605-614.
135. Molina JA, Jimenez-Jimenez FJ, Hernanz A, Fernandez-Vivancos E, Medina S. et al. 2002. Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease. J Neural Transm 109:1035-1044.
136. Moore SA. 2001. Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro. J Mol Neurosci 16:195-200.
137. Mukhopadhyay D, Mukherjea M. 1994. Inhibition of two HMP shunt pathway enzymes by fatty acids and their CoA esters in developing human brain: Role of fatty acid binding protein. Indian J Biochem Biophys 31:464-468.
138. Murphy S. 2000. Production of nitric oxide by glial cells: Regulation and potential roles in the CNS. Glia 29:1-13.
139. Nagatsu T. 2004. Progress in monoamine oxidase (MAO) research in relation to genetic engineering. Neurotoxicology 25:11-20.
140. Nasr LB, Monet JD, Lucas P, Bader CA. 1989. Vitamin D3 and glucose-6-phosphate dehydrogenase in rat duodenal epithelial cells. Am J Physiol 257:G760-G765.
141. Ng TF, Lee FK, Song ZT, Calcutt NA, Lee AY, et al. 1998. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice. Diabetes 47:961-966.
142. Niedermüller H. 1986. Effects of aging on the recycling via the pentose cycle and on the kinetics of glycogen and protein metabolism in various organs of the rat. Arch Gerontol Geriatr 5:305-316.
143. Ninfali P, Aluigi G, Balduini W, Pompella A. 1997. Glucose-6-phosphate dehydrogenase activity is higher in the olfactory bulb than in other brain areas. Brain Res 744:138-142.
144. Ninfali P, Aluigi G, Pompella A. 1998. Postnatal expression of glucose-6-phosphate dehydrogenase in different brain areas. Neurochem Res 23:1197-1204.
145. Ninfali P, Ditroilo M, Capellacci S, Biagiotti E. 2001. Rabbit brain glucose-6-phosphate dehydrogenase: Biochemical properties and inactivation by free radicals and 4-hydroxy-2-nonenal. Neuroreport 12:4149-4153.
146. Novello F, McLean P. 1968. The pentose phosphate pathway of glucose metabolism. Biochem J 107:775-791.
147. O'Brien MM, Schofield PJ. 1980. Polyol-pathway enzymes of human brain. Partial purification and properties of aldose reductase and hexonate dehydrogenase. Biochem J 187:21-30.
148. Palmer AM. 1999. The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease. J Neural Transm 106:317-328.
149. Pandolfi PP, Sonati F, Rivi R, Mason P, Grosveld F, et al. 1995. Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J 14:5209-5215.
150. Pannunzio P, Hazell AS, Pannunzio M, Rao KV, Butterworth RF. 2000. Thiamine deficiency results in metabolic acidosis and energy failure in cerebellar granule cells: An in vitro model for the study of cell death mechanisms in Wernicke's encephalopathy. J Neurosci Res 62:286-292.
151. Pitkin SR, Savage LM. 2001. Aging potentiates the acute and chronic neurological symptoms of pyrithiamine-induced thiamine deficiency in the rodent. Behav Brain Res 119:167-177.
152. Prothmann C, Wellard J, Berger J, Hamprecht B, Verleysdonk S. 2001. Primary cultures as a model for studying ependymal functions: Glycogen metabolism in ependymal cells. Brain Res 920:74-83.
153. Puglielli L, Tanzi RE, Kovacs DM. 2003. Alzheimer's disease: The cholesterol connection. Nat Neurosci 6:345-351.
154. Qi K, Hall M, Deckelbaum RJ. 2002. Long-chain polyunsaturated fatty acid accretion in brain. Curr Opin Clin Nutr Metab Care 5:133-138.
155. Rahman B, Kussmaul L, Hamprecht B, Dringen R. 2000. Glycogen is mobilized during the disposal of peroxides by cultured astroglial cells from rat brain. Neurosci Lett 290:169-172.
156. Reiss AB, Siller KA, Rahman MM, Chan ES, Ghiso J, et al. 2004. Cholesterol in neurologic disorders of the elderly: Stroke and Alzheimer's disease. Neurobiol Aging 25:977-989.
157. 13C2, 6, 6-2H2]glucose. Biochem J 302(Pt 1):31-38.
158. Russell RL, Siedlak SL, Raina AK, Bautista JM, Smith MA, et al. 1999. Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. Arch Biochem Biophys 370:236-239.
159. Rust RS Jr, Carter JG, Martin D, Nerbonne JM, Lampe PA, et al. 1991. Enzyme levels in cultured astrocytes, oligodendrocytes and Schwann cells, and neurons from the cerebral cortex and superior cervical ganglia of the rat. Neurochem Res 16:991-999.
160. Sankarapandi S, Zweier JL, Mukherjee G, Quinn MT, Huso DL. 1998. Measurement and characterization of superoxide generation in microglial cells: Evidence for an NADPH oxidase-dependent pathway. Arch Biochem Biophys 353:312-321.
161. Schedin S, Nilsson M, Chojnacki T, Dallner G. 1998. Alterations in the biosynthesis of cholesterol, dolichol and dolichyl-P in the genetic cholesterol homeostasis disorder, Niemann-Pick type C disease. Biochim Biophys Acta 1394:177-186.
162. Schenk G, Duggleby RG, Nixon PF. 1998. Heterologous expression of human transketolase. Int J Biochem Cell Biol 30:369-378.
163. Schulz JG, Bosel J, Stoeckel M, Megow D, Dirnagl U, et al. 2004. HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis. J Neurochem 89:24-32.
164. Sedlak TW, Snyder SH. 2004. Bilirubin benefits: Cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 113:1776-1782.
165. Sengupta T, Datta C, Dasgupta J, De K, De S, et al. 1985. Role of hexosemonophosphate shunt pathway in glucose metabolism in developing human foetal brain. Indian J Biochem Biophys 22:208-210.
166. Sheu KF, Calingasan NY, Dienel GA, Baker H, Jung EH, et al. 1996. Regional reductions of transketolase in thiaminedeficient rat brain. J Neurochem 67:684-691.
167. Singh R, Pathak DN. 1990. Lipid peroxidation and glutathione peroxidase, glutathione reductase, superoxide dismutase, catalase, and glucose-6-phosphate dehydrogenase activities in FeCl3-induced epileptogenic foci in the rat brain. Epilepsia 31:15-26.
168. Sinicropi DV, Kauffman FC. 1979. Retrograde alteration of 6-phosphogluconate dehydrogenase in axotomized superior cervical ganglia of the rat. J Biol Chem 254:3011-3017.
169. Slezak M, Pfrieger FW. 2003. New roles for astrocytes: Regulation of CNS synaptogenesis. Trends Neurosci 26:531-535.
170. Smith ER, Barker KL. 1974. Effects of estradiol and nicotinamide adenine dinucleotide phosphate on the rate of synthesis of uterine glucose 6-phosphate dehydrogenase. J Biol Chem 249:6541-6547.
171. Song HP, Das B, Srivastava SK. 1987. Microdetermination of aldose and aldehyde reductases from human tissues. Curr Eye Res 6:1001-1006.
172. Soucek T, Cumming R, Dargusch R, Maher P, Schubert D. 2003. The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39:43-56.
173. Spence AM, Graham MM, Muzi M, Freeman SD, Link JM, et al. 1997. Feasibility of imaging pentose cycle glucose metabolism in gliomas with PET: Studies in rat brain tumor models. J Nucl Med 38:617-624.
174. Spencer N, Hopkinson DA. 1980. Biochemical genetics of the pentose phosphate cycle: Human ribose 5-phosphate isomerase (RPI) and ribulose 5-phosphate 3-epimerase (RPE). Ann Hum Genet 43:335-342.
175. Strobel HW, Thompson CM, Antonovic L. 2001. Cytochromes P450 in brain: Function and significance. Curr Drug Metab 2:199-214.
176. Sykes JEC, Lopez-Cardozo M, van den Bergh SG. 1986. Relationship between the pentose-phosphate pathway and the de novo synthesis of fatty acids and cholesterol in oligodendrocyte-enriched glial cultures. Neurochem Int 8:77-82.
177. Tian WN, Braunstein LD, Pang J, Stuhlmeier KM, Xi QC, et al. 1998. Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J Biol Chem 273:10609-10617.
178. Tyson RL, Perron J, Sutherland GR. 2000. 6-Aminonicotinamide inhibition of the pentose phosphate pathway in rat neocortex. Neuroreport 11:1845-1848.
179. Ulusu NN, Sahilli M, Avci A, Canbolat O, Ozansoy G, et al. 2003. Pentose phosphate pathway, glutathione-dependent enzymes and antioxidant defense during oxidative stress in diabetic rodent brain and peripheral organs: Effects of stobadine and vitamin E. Neurochem Res 28:815-823.
180. Vallejo CG, Marco R, Sebastian J. 1971. The glucose 6-phosphate metabolic crossroads in brain. Studies at the enzyme level. Arch Biochem Biophys 147:41-48.
181. Vogel R, Hamprecht B, Wiesinger H. 1998a. Malic enzyme isoforms in astrocytes: Comparative study on activities in rat brain tissue and astroglia-rich primary cultures. Neurosci Lett 247:123-126.
182. Vogel R, Jennemann G, Seitz J, Wiesinger H, Hamprecht B. 1998b. Mitochondrial malic enzyme: Purification from bovine brain, generation of an antiserum, and immunocytochemical localization in neurons of rat brain. J Neurochem 71:844-852.
183. Vogel R, Wiesinger H, Hamprecht B, Dringen R. 1999. The regeneration of reduced glutathione in rat forebrain mitochondria identifies metabolic pathways providing the NADPH required. Neurosci Lett 275:97-100.
184. Wagner KR, Sharp FR, Ardizzone TD, Lu A, Clark JF. 2003. Heme and iron metabolism: Role in cerebral hemorrhage. J Cereb Blood Flow Metab 23:629-652.
185. Wang JJ, Martin PR, Singleton CK. 1997. A transketolase assembly defect in a Wernicke-Korsakoff syndrome patient. Alcohol Clin Exp Res 21:576-580.
186. Weisz KS, Schofield PJ, Edwards MR. 1985. Human brain 6-phosphogluconate dehydrogenase: Purification and kinetic properties. J Neurochem 44:510-517.
187. Wiesinger H. 2001. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog Neurobiol 64:365-391.
188. Wiesinger H, Thiess U, Hamprecht B. 1990. Sorbitol pathway activity and utilization of polyols in astroglia-rich primary cultures. Glia 3:277-282.
189. Winkler BS, DeSantis N, Solomon F. 1986. Multiple NADPH-producing pathways control glutathione (GSH) content in retina. Exp Eye Res 43:829-847.
190. Wood T. 1974. The detection and occurrence of multiple forms of D-ribose 5-phosphate ketol isomerase. Arch Biochem Biophys 160:40-46.
191. Wood T. 1986. Physiological functions of the pentose phosphate pathway. Cell Biochem Funct 4:241-247.
192. Xu ZP, Wawrousek EF, Piatigorsky J. 2002. Transketolase haploinsufficiency reduces adipose tissue and female fertility in mice. Mol Cell Biol 22:6142-6147.
193. Yoshida S, Saitoh T, Takeshita M. 1988. Hydrogen transfer by NADPH-dependent reductases in elongation of very-longchain saturated and polyunsaturated fatty-acyl-CoA in swine cerebral microsomes. Biochim Biophys Acta 958:361-367.
194. Zakhary R, Poss KD, Jaffrey SR, Ferris CD, Tonegawa S, et al. 1997. Targeted gene deletion of heme oxygenase 2 reveals neural role for carbon monoxide. Proc Natl Acad Sci USA 94:14848-14853.
195. Zekry D, Epperson TK, Krause KH. 2003. A role for NOX NADPH oxidases in Alzheimer's disease and other types of dementia? IUBMB Life 55:307-313.
196. Zimatkin SM, Zimatkina TI. 1996. Thiamine deficiency as predisposition to, and consequence of, increased alcohol consumption. Alcohol Alcohol 31:421-427.
197. Zimmer HG, Lankat-Buttgereit B, Kolbeck-Rühmkorff C, Nagano T, Zierhut W. 1992. Effects of norepinephrine on the oxidative pentose phosphate pathway in the rat heart. Circ Res 71:451-459.
198. Zubaran C, Fernandes JG, Rodnight R. 1997. Wernicke-Korsakoff syndrome. Postgrad Med J 73:27-31.